Cancer Biology

1151 Identification of human CD4+ T cell populations with distinct antitumor activity.

1150 A large feasibility study shows that a cancer blood test and PET-CT imaging can detect some cancers at an early stage.

1149 Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.

1148 Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.

1147 Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy.

1146 Molecular and functional extracellular vesicle analysis using nanopatterned microchips monitors tumor progression and metastasis.

1145 Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1.

1144 Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.

1143 Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1.

1142 The human tumor microbiome is composed of tumor type–specific intracellular bacteria.

1141 The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.

1140 Natural hybridization reveals incompatible alleles that cause melanoma in swordtail fish.

1139 Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.

1138 Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.

1137 Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.

1136 The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.

1135 Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation.

1134 Germline mutations in the Elongator complex gene ELP1 predispose individuals to the development of childhood medulloblastoma.

1133 Integrating genomic features for non-invasive early lung cancer detection.

1132 IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia.

Free Images for Presentation: sunipix SUNIPIX